Investigation of Drug Release from PEO Tablet Matrices in the Presence of Vitamin E as Antioxidant

被引:4
作者
Shojaee, Saeed [1 ]
Nokhodchi, Ali [3 ,5 ,6 ]
Cumming, Iain [1 ]
Alhalaweh, Amjad [4 ]
Kaialy, Waseem [2 ]
机构
[1] Univ Kent, Medway Sch Pharm, Chem & Drug Delivery Grp, Chatham ME4 4TB, Kent, England
[2] Wolverhampton Univ, Fac Sci & Engn, Sch Pharm, Wolverhampton WV1 1LY, W Midlands, England
[3] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England
[4] Uppsala Univ, Uppsala Biomed Ctr, Dept Pharm, Uppsala, Sweden
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[6] Tabriz Univ Med Sci, Fac Pharm, Tabriz, Iran
关键词
Controlled release; Drug solubility; PEO matrices; Stability; Vitamin E; MOLECULAR-WEIGHT POLYETHYLENE; ORAL CONTROLLED-RELEASE; OXIDE; ADDITIVES; HYDROGELS; DESIGN;
D O I
10.2174/1567201812666150326113052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to investigate the influence of drug type on the release of drug from PEO matrix tablets accompanied with the impact of vitamin E succinate as antioxidant. The result showed that the presence of vitamin E promoted a stable release rate of soluble drug propranolol HCl from aged PEO matrix tablets, which was similar to fresh sample, regardless of molecular weight ( MW) of PEO. However, the influence of the presence of vitamin E on the release rate of partially soluble drug, theophylline, was dependent on the MW of PEO; i.e., fast and unstable drug release was obtained in the case of low MW PEO 750 whereas stable drug release was obtained in the case of high MW PEO 303. The release of low water-soluble drug zonisamide was stable regardless of both the presence of vitamin E and the MW of PEO. The presence of vitamin E slightly slowed the release of zonisamide from aged PEO 303 matrices but not PEO 750 matrices. Therefore, in order to achieve a suitable controlled release profile from PEO matrices, not only the presence of vitamin E but also the solubility of the drug and the MW of polyox should be considered.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 33 条
[1]  
[Anonymous], 2003, USP PHARM 26 NAT FOR, V26, P320
[2]   Stabilisation of ultra-high molecular weight polyethylene with Vitamin E [J].
Bracco, P. ;
Brunella, V. ;
Zanetti, M. ;
Luda, M. P. ;
Costa, L. .
POLYMER DEGRADATION AND STABILITY, 2007, 92 (12) :2155-2162
[3]   Improving synthetic hindered phenol antioxidants:: learning from vitamin E [J].
Breese, KD ;
Lamèthe, JF ;
DeArmitt, C .
POLYMER DEGRADATION AND STABILITY, 2000, 70 (01) :89-96
[4]  
Dhawan S., 2005, PHARM TECHNOL, V29, P82
[5]  
GRAHAM NB, 1984, BIOMATERIALS, V5, P27, DOI 10.1016/0142-9612(84)90063-2
[6]  
Gupta C. R., 2013, J PHARM RES, V6, P249
[7]  
Gutteridge J., 1999, FREE RADICALS BIOL M
[9]   An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression [J].
Kaialy, Waseem ;
Larhrib, Hassan ;
Chikwanha, Brian ;
Shojaee, Saeed ;
Nokhodchi, Ali .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 464 (1-2) :53-64
[10]   Psyllium: a promising polymer for sustained release formulations in combination with HPMC polymers [J].
Kaialy, Waseem ;
Emami, Parastou ;
Asare-Addo, Kofi ;
Shojaee, Saeed ;
Nokhodchi, Ali .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2014, 19 (03) :269-277